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Abstract 
Introduction:  new modalities like Optical coherence
tomography  (Oct)  allow  non-invasive  examination
of the internal structure of biological tissue in vivo.
the  potential  benefits  and  limitations  of  this  new
technology for the detection and evaluation of bladder
cancer were examined in this study.
Materials  and  Methods:  Between  January  2007  and
January 2008, 52 patients who underwent transurethral
bladder biopsy or tuR-Bt for surveillance or due to
initial suspicion of urothelial carcinoma of the bladder
were enrolled in this study. In total, 166 lesions were
suspicious for malignancy according to standard white
light cystoscopy. all suspicious lesions were scanned
and interpreted during perioperative cystoscopy using
Oct.  cold  cup  biopsies  and/or  tuR-B  was  per-
formed for all these lesions. for this study we used an
Oct-device  (nirisﾮ,  Imaluxﾮ,  cleveland,  us),  that
utilizes near-infrared light guided through a flexible fi-
bre-based applicator, which is placed into the bladder
via the working channel of the cystoscope. the tech-
nology provides high spatial resolution on the order of
about  10-20  ﾵm,  and  a  visualization  of  tissue  to  a
depth of about 2 mm across a lateral span of about 2
mm in width. the device used received market clear-
ance from the fda and cE approval in germany. the
diagnostic  and  surgical  procedure  was  videotaped 
and  analyzed  afterwards  for  definitive  matching  of
scanned  and  biopsied  lesion.  the  primary  aim  of 
this study was to determine the level of correlation 
between Oct interpretation and final histological re-
sult. 
Results: Of  166  scanned  Oct  images,  102  lesions
(61.4%)  matched  to  the  same  site  where  the
biopsy/tuR-Bt was taken according to videoanalysis.
Only these video-verified lesions were used for further
analysis. Of all analyzed lesions 88 were benign (in-
flammation, edema, hyperplasia etc.) and 14 were ma-
lignant  (cIs,  ta,  t1,  t2)  as  shown  by  final  histo  -
pathology. 
all 14 malignant lesions were detected correctly by
Oct.  furthermore  all  invasive  tumors  were  staged
correctly by Oct regarding tumor growth beyond the
lamina propria. there were no false negative lesions
detected by Oct. sensitivity of Oct for detecting the
presence of a malignant lesion was 100% and sensitiv-
ity for detection of tumor growth beyond the lamina
propria  was  100%  as  well.  specificity  of  Oct  for
presence of malignancy was 65%, due to the fact that
a number of lesions were interpreted as false positive
by Oct. 
Conclusion: as a minimally invasive technique, Oct
proved to have extremely high sensitivity for detection
of malignant lesions as well as estimation of whether
a tumor has invaded beyond the lamina propria. How-
ever, specificity of Oct within the bladder was im-
paired (65%), possibly due to a learning curve and/or
the relatively low spatial resolution and visualization
depth  of  the  Oct  technology.  further  studies  and
technical development are needed to establish an ade-
quate surrogate for optical biopsy.
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IntROductIOn
Early diagnosis and tumor specific follow up of pa-
tients with bladder cancer is essential for an optimal
and  timely  induction  of  an  individualized  therapy.
standard non-invasive diagnostic techniques like ultra-
sound (us), computed tomography (ct) or magnetic
resonance imaging (MRI) give only restricted informa-
tion regarding the entity of a lesion (malignant or be-
nign)  within  the  bladder.  furthermore  these  tech-
niques do not give reliable information regarding tu-
mor invasion (superficial growth, invasion of the lami-
na propria, invasion of musculature etc.). In many cas-
es invasive bladder biopsy, or tuR-Bt, is needed to
diagnose a specific disease and exclude or confirm ma-
lignant tumor presence. the additional use of Optical
coherence tomography (Oct) could enable the ex-
aminer to decide whether a lesion must be biopsied or
whether it can be confidently determined as benign.
Oct as an optical surrogate for biopsy could elimi-
nate  the  need  for  primary  surgical  intervention  and
anaesthesia for diagnosis and follow up of bladder le-
sions.  this  prospective  mono-center  study  aims  to
evaluate the clinical use and feasibility of Oct in the
detection of bladder cancer. 
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Between January 2007 and January 2008, 52 patients
who underwent transurethral bladder biopsy or tuR-
Bt  for  surveillance  or  due  to  initial  suspicion  of
urothelial carcinoma of the bladder were enrolled in
this study. Patientsﾴ age ranged from 21 to 91 years.
this study included 32 patients with a positive history
of urothelial cancer and 20 patients with initial suspi-
cion  for  malignancy  (positive  cytology,  gross  hema-
turia, suspicious cystoscopical finding etc.). Excluded
from this study were patients with an age below 18
years, pregnant patients and patients without informed
consent.
all examinations followed a standardized protocol.
first  every  patient  underwent  a  cystoscopy  in  white
light using a standard cystoscope sheath (25 charri￨re)
with an integrated working channel using 30ﾰ degree
optics, or sometimes 70ﾰ degree optics (storzﾮ, tutt  -
lingen,  germany)  if  needed.  Before  tissue  removal
(biopsy/tuR-Bt), all suspicious lesions were scanned
and evaluated during the procedure using Oct. In our
investigation  we  used  an  Oct-device  (nirisﾮ,
Imaluxﾮ,  cleveland,  us)  that  utilizes  near-infrared
light guided through a flexible fibre-based applicator,
which is placed into the bladder via the working chan-
nel of the cystoscope. Oct - scanning was performed
using a 1300-nm 10-mW superluminescent diode with
an applicator with an outer diameter of 2.7-mm. Oct
scans  with  a  duration  of  approximately  1.5  seconds
each generated 200 x 200-pixel images. this enabled
visualisation of surface tissue and sub-surface tissue
microstructure.  the  technique  provided  high  spatial
resolution on the order of about 10-20 ﾵm, and a visu-
alization of tissue to a depth of about 2 mm across a
lateral span of about 2 mm in width. Oct does not
require a conducting medium and can therefore image
through air or water [7, 8]. 
a specially designed documentation sheet was used
to record the exact location of each lesion within the
bladder and its morphology in white light (flat, papil-
lary, solid etc.). the whole procedure of cystoscopy,
Oct scanning and tissue removal was videotaped for
later  analysis.  use  of  the  diagnostic  device  was  ap-
proved by the ethics committee of the lMu Munich,
germany.
REsults
Of  166  scanned  Oct  images,  102  lesions  (61.4%)
matched to the same site where the biopsy/tuR-Bt
was taken according to videoanalysis. Only these video-
verified lesions were used for further statistical analysis.
Of the evaluable lesions, 88 were benign (acute inflam-
mation n = 9, chronic inflammation n = 44, edema n =
3, normal tissue n = 12, scaring = 5, hyperplasia n = 1,
metaplasia n = 6, low grade dysplasia n = 4, intraep-
ithelial benign findings n = 4) and 14 were malignant
(high grade dysplasia n = 2, cIs n = 1, ta n = 6, t1 n
= 3, t2 n = 2) as shown by final histopathology. 
all 14 histologically proven malignant lesions were
detected correctly by Oct. furthermore all invasive
tumors were staged correctly by Oct as having tumor
growing beyond the lamina propria. no lesions were
false negative as detected by Oct. Of 88 histologically
benign lesions, 31 turned out to be false positive and
57  to  be  correctly  negative  in  Oct.  sensitivity  of
Oct regarding the presence of a malignant lesion was
100% and sensitivity regarding tumor growth beyond
the  lamina  propria  was  100%  as  well.  specificity  of
Oct for presence of malignancy was 65%. false posi-
tive  (n  =  31)  lesions  were  misinterpreted  edemas,





Tumor invades the 
Lamina propria
Image  1: Oct scan: lateral scanning provides two-dimen-
sional images, that are called analogous to ultrasound B-scan. 
Image 2: Oct probe (￘ 2.7 mm), inserted into the bladder
via the working channel of the cystoscope sheath. 
Image 3: layers of a healthy urinary bladder as generated by
Oct. 
Image 4: Oct scan: tumor invades the lamina propria.
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lesions were not clearly demarked using Oct. tumor
invasion beyond the lamina propria was detected cor-
rectly in all five cases. In 16 benign lesions, an invasion
of the lamina propria was suspected in Oct, but not
proven in final histology. 
dIscussIOn
standard non-invasive imaging techniques like conven-
tional ultrasonography, ct, and MRI have significant
limitations  due  to  low  spatial  resolution  and  subse-
quent  inability  to  provide  sufficient  histopathologic
detail [5, 6]. determination of a lesion as clearly su-
perficial is barely possible, as well as accurate judge-
ment of the invasion depth, unless the tumor is far ad-
vanced or widespread. furthermore the classification
of a tumorous lesion within the bladder to be malig-
nant  or  benign  is  nearly  impossible  using  standard
imaging techniques. the concordance of ct finding
and pathological result of a cystectomy specimen is
only between 65% to 80% [1]. 
Even  more  difficult  is  the  exact  evaluation  of  a
non-muscle invasive tumor of the human bladder us-
ing  these  techniques.  there  is  no  way  to  use  ultra-
sonography, ct, or MRI for grading of a tumor. cur-
rently, a histopathologically examined actual specimen
in needed for every final diagnosis Obtaining a speci-
men requires an invasive procedure that is often per-
formed with regional or general anesthesia. this pro-
cedure is not only a physical and psychological stress
for the patient, but is also a high financial burden for
the health care system. 
for a long time now, there has been a need for a
minimally invasive technology that permits differentia-
tion of malignant and benign findings in the bladder,
and moreover to judge the invasion depth of a tumor.
such a technology should provide the diagnostic infor-
mation as soon as possible, hopefully „online“ during
cystoscopy. the scanned image should be interpretable
by the examining physician himself, so that the necessi-
ty of proceeding to an invasive procedure can be im-
mediately assessed. the advantage of a technology like
this is the ability of the urologist to make an immediate
diagnosis  in  an  outpatient  setting,  thus  avoiding  the
need to take a biopsy and subject the patient to an in-
vasive procedure under anesthesia. such an approach
would reduce not only risk for the patient, but could
also save expenses for the health care system. 
Optical coherence tomography is already success-
fully in use in the fields of Ophthalmology, dermatol-
ogy or cardiology [2-4].
In urology, the first studies using this technology
are being published. In different animal trials [5, 6] as
well as in humans [7-9] it was possible to detect carci-
noma in situ which is difficult to diagnose with white
light cystoscopy. Papillary tumors could also be detect-
ed  by  Oct.  Manyak  et  al.  [10]  analyzed  261  Oct-
scans in 24 patients. Of 87 Oct scanned areas, 29 of
36 visually suspicious lesions and 35 of 35 visually un-
suspicious lesions were correctly judged using Oct.
Of  16  areas  with  papillary  urothelial  tumors,  all  16
were  detected  correctly  as  tumors,  whereas  9  of  10
were diagnosed correctly to be invasive. In this study,
Oct had a sensitivity of 100% and a specificity of
89%. the positive predictive value was 75% and the
negative predictive value was 100%. 
Oct is also currently used in the differentiation of
the neurovascular bundle during radical prostatectomy
in animal models [11] as well as in human trials [12].
despite  promising  initial  reports,  the  currently
used, in vivo, Oct devices have certain limitations,
which were apparent during this study. the 2 mm in-
vasion depth of the technology is not always suffi-
cient to judge the invasion depth of a tumor, especial-
ly if the diameter of a tumor is already larger than 2
mm before reaching the area of the lamina propria,
making the judgement of muscle invasion impossible.
unfortunately  there  are  also  solid  and  papillary  tu-
mors, where invasion depth cannot be judged suffi-
ciently. 
Moreover  the  resolution  of  currently  available  in
vivo devices does not allow the differentiation of a
single cell layer or the morphology of a single cell.
One new technology that proved to have a far higher
resolution was confocal lasermicroscopy. In vitro stud-
ies showed the visualization of single cells which gives
the opportunity to judge the grading of a cell [13], but
the invasion depth of this technique is far below that
of Oct. using Oct, imaging of tissue structures has
a resolution 20-times higher than that of high resolu-
tion-ultrasound. thus, depending on the Oct device
used (in vitro / in vivo), structures as small as 4-20 ﾵm
can be visualized. 
accurate differentiation between inflammative tis-
sue and carcinoma in situ is not sufficiently possible
yet by Oct. also the classification (edema, cIs, scar
tissue etc.) of a lesion using Oct turns out to be ex-
tremely difficult. 
the high rate of drop-outs in our study, lesions in
which biopsy and scanning area could not be matched
sufficiently using later video-analysis, can be explained
by the need to change the cystosope sheath and biopsy
sheath  between  each  lesion  within  the  bladder.  to
avoid  unnecessary  urethral  damage  only  one  change
was allowed between the cystoscopy sheath, which had
to be used for Oct due to a larger diameter of the
working channel, and the resectoscope sheath, which
was used for biopsy or tuR-Bt. so if there was more
than one lesion within the bladder scanned by Oct, it
was extremely difficult to find the exact site (probe di-
ameter  of  2.7mm)  again  after  changing  the  sheaths.
since no other marking tool was used on the scanned
Oct  sites,  only  slightly  more  than  60%  of  biopsy-
and Oct scanned sites were matching according to
the later videoanalysis. 
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Table  1.  sensitivity  and  specificity  of  Oct  regarding  the




Oct positive 14  31 
Oct negative 0  57 
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which  allows  the  performance  of  Oct  and
biopsy/tuR-Bt at the same time is needed. Other-
wise a marking tool should be used to avoid the high
drop-out  rate  we  experienced  in  this  study.  despite
these drawbacks, Oct proved to be a promising tech-
nology that may help to avoid invasive procedures for
lesions which could be clearly defined as benign. fur-
thermore, with Oct it was possible to classify tumors
as invasive or going beyond the lamina propria. With a
higher resolution and a greater invasion depth, Oct
technology could potentially be an excellent surrogate
for optical biopsy. a study combining Oct and con-
focal lasermicroscopy would be interesting. It would
be interesting to use Oct technology to judge espe-
cially flat lesions like carcinoma in situ, since the inva-
sion depth would be sufficient for this type of lesion.
also, evaluation of the resection ground of a tumor
could be checked for completeness of tumor removal
and sufficient removal of musculature. 
cOnclusIOn
as a minimally invasive technology for the detection
of  bladder  cancer,  Oct  showed  an  extremely  high
sensitivity for malignant lesions as well as estimation
of whether a tumor has invaded beyond the lamina
propria. However, specificity of Oct within the blad-
der  was  impaired  (65%),  possibly  due  to  a  learning
curve and/or the relatively low spatial resolution and
visualization depth of the Oct technology used. fur-
ther studies and technical development are needed to
establish an adequate surrogate for optical biopsy.
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